Loading...
Kyprolis (Carfilzomib) Received New Indications as Combination Therapy for Use in Relapsed and/or Refractory Multiple Myeloma
Na minha lista:
| Udgivet i: | Am Health Drug Benefits |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Engage Healthcare Communications, LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013842/ https://ncbi.nlm.nih.gov/pubmed/27668053 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|